Alcidion Group

Alcidion Group Acquisitions (Net)

Acquisitions (Net) of Alcidion Group (ALC.AX) as of Nov 10, 2026.

Acquisitions (Net)

0.00AUD

Last updated:

Acquisitions (Net) of Alcidion Group is 2024 0.00 AUD. Acquisitions (Net) of Alcidion Group was 2023 -2.69 M AUD. It decreases by % higher compared to the previous year.

The Alcidion Group Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
0.00 AUD
Jan 1, 2018
-591,800.00 AUD
Jan 1, 2019
-1.48 M AUD
Jan 1, 2020
-238,200.00 AUD
Jan 1, 2021
-9.53 M AUD
Jan 1, 2022
-59.43 M AUD
Jan 1, 2023
-2.69 M AUD
Jan 1, 2024
0.00 AUD
The Alcidion Group Acquisitions (Net) history
YEARAcquisitions (Net)YoY
0.00AUD-100.00%
-2.69 MAUD-95.48%
-59.43 MAUD+523.63%
-9.53 MAUD+3,900.84%
-238,200.00AUD-83.86%
-1.48 MAUD+149.41%
-591,800.00AUD—
0.00AUD-100.00%
5.33 MAUD—
0.00AUD-100.00%
370,000.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

On Eulerpool you can find the complete historical development of Acquisitions (Net) Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Alcidion Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Alcidion Group

All Key Metrics — Alcidion Group